ZURICH/BERLIN, Aug 2(Reuters) - Here are some of the
main factors that may affect Swiss stocks on Wednesday:
ROCHE ROG.S
Swiss drugmaker Roche's Genentech subsidiary has accused a
Novartis NOVN.S unit of infringing one of its patents by
selling a generic version of its blockbuster lung disease drug
Esbriet, after an earlier lawsuit failed to keep the generic
drug off the market. urn:newsml:reuters.com:*:nL1N39I30E
COMPANY STATEMENTS
*Garmin Ltd GRMN.BN - Second-Quarter Results Due
*Interroll INRN.S - Defended Market Position In H1 2023
With Solid Order Intake urn:newsml:reuters.com:*:nTUC3FT5M4
ANALYSTS' VIEWS
NESTLE NESN.S - HSBC RAISES TO BUY FROM HOLD, RAISES
TARGET PRICE TO CHF 120 FROM CHF 119
DOCMORRIS AG DOCM.S - CREDIT SUISSE CUTS TARGET PRICE TO
CHF 35 FROM CHF 40
ECONOMY
Swiss Q3 Consumer Confidence Index due at 0700 GMT
Swiss July Manufacturing PMI due at 0730 GMT. Seen at 44.00.
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))